Clinical Trial Update: Glyburide Advantage in Malignant Edema and Stroke Pilot [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 pilot trial results evaluate glyburide for malignant edema in ischemic stroke, with ischemic stroke as the primary condition studied.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Cerebral Edema
• Stroke

Drugs mentioned

• Glyburide (glyburide)

Snippet

Sponsor: Remedy Pharmaceuticals, Inc. | Conditions: Ischemic Stroke | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-06-06